pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

18,993 catalysts · 18,987 approval · 5,000 device 510k · 4,970 phase readout · 4,728 grant · 2,440 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 28 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: filing×type: approval×clear all
type
  • approval18,987
  • device 510k5,000
  • phase readout4,970
  • grant4,728
  • 8k filing2,440
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • earnings296
  • therapy area
    • Ophthalmology5

    Week of Apr 1, 2002

    6
    ›Apr 1, 2002approval8884d agoCONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 1, 2002approval8884d agoTRILEPTAL (OXCARBAZEPINE) — FDA approvalOXCARBAZEPINE

    Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL

    full page →OXCARBAZEPINE →fda approvals ↗
    ›Apr 1, 2002approval8884d agoTRILEPTAL (OXCARBAZEPINE) — FDA approvalOXCARBAZEPINE

    Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

    full page →OXCARBAZEPINE →fda approvals ↗
    ›Apr 2, 2002approval8883d agoIDARUBICIN HYDROCHLORIDE — FDA approvalIDARUBICIN HYDROCHLORIDE

    Sponsor: PFIZER. Form: SOLUTION. Route: INTRAVENOUS

    full page →IDARUBICIN HYDROCHLORIDE →fda approvals ↗
    ›Apr 3, 2002approval8882d agoSODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (SODIUM CHLORIDE) — FDA approvalRevalesio Corp

    Sponsor: B BRAUN. Form: SOLUTION. Route: IRRIGATION

    full page →fda approvals ↗
    ›Apr 3, 2002approval8882d agoLACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE) — FDA approvalCALCIUM CHLORIDE 10%

    Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION

    full page →CALCIUM CHLORIDE 10% →fda approvals ↗

    Week of Apr 8, 2002

    6
    ›Apr 9, 2002approval8876d agoMETADATE CD (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE CD

    Sponsor: AYTU BIOPHARMA. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →METADATE CD →fda approvals ↗
    ›Apr 11, 2002approval

    Week of Apr 15, 2002

    8
    ›Apr 15, 2002approval8870d agoRINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE) — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: B BRAUN. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Apr 15, 2002approval

    Week of Apr 22, 2002

    2
    ›Apr 26, 2002approval8859d agoFIORICET W/ CODEINE (ACETAMINOPHEN) — FDA approvalIGC Pharma, Inc.

    Sponsor: ACTAVIS LABS UT INC. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 26, 2002approval

    Week of Apr 29, 2002

    5
    ›Apr 29, 2002approval8856d agoCENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approvalCENESTIN

    Sponsor: ASPEN. Form: TABLET. Route: ORAL

    full page →CENESTIN →fda approvals ↗
    ›Apr 29, 2002approval

    Week of May 6, 2002

    3
    ›May 6, 2002approval8849d agoTEGRETOL-XR (CARBAMAZEPINE) — FDA approvalcarbamazepine ER

    Sponsor: NOVARTIS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›May 9, 2002approval

    Week of May 13, 2002

    7
    ›May 13, 2002approval8842d agoMALARONE PEDIATRIC (ATOVAQUONE) — FDA approvalatovaquone

    Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

    full page →atovaquone →fda approvals ↗
    ›May 15, 2002approval

    Week of May 20, 2002

    7
    ›May 22, 2002approval8833d agoDEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approvalMETHYLPREDNISOLONE ACETATE

    Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION

    full page →METHYLPREDNISOLONE ACETATE →fda approvals ↗
    ›May 22, 2002approval

    Week of May 27, 2002

    2
    ›May 28, 2002approval8827d agoIFOSFAMIDE — FDA approvalIFOSFAMIDE

    Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION

    full page →IFOSFAMIDE →fda approvals ↗
    ›May 31, 2002approval

    Week of Jun 3, 2002

    4
    ›Jun 3, 2002approval8821d agoTHALLOUS CHLORIDE TL 201 (THALLOUS CHLORIDE TL-201) — FDA approval

    Sponsor: CURIUM. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jun 5, 2002approval
    ← prev
    page 75 of 380
    next →
    8874d ago
    ACETAMINOPHEN AND CODEINE PHOSPHATE (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Apr 12, 2002approval8873d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

    Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL

    full page →Restasis →fda approvals ↗
    ›Apr 12, 2002approval8873d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

    Sponsor: NOVARTIS. Form: INJECTABLE. Route: INJECTION

    full page →Restasis →fda approvals ↗
    ›Apr 12, 2002approval8873d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

    Sponsor: NOVARTIS. Form: SOLUTION. Route: ORAL

    full page →Restasis →fda approvals ↗
    ›Apr 12, 2002approval8873d agoPRED MILD (PREDNISOLONE ACETATE) — FDA approvalprednisolone acetate

    Sponsor: ABBVIE. Form: SUSPENSION/DROPS. Route: OPHTHALMIC

    full page →prednisolone acetate →fda approvals ↗
    8870d ago
    LACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE) — FDA approvalBaxter Healthcare Corp

    Sponsor: B BRAUN. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Apr 16, 2002approval8869d agoEPIPEN E Z PEN (EPINEPHRINE) — FDA approvaladrenaline

    Sponsor: VIATRIS. Form: INJECTABLE. Route: INTRAMUSCULAR

    full page →adrenaline →fda approvals ↗
    ›Apr 16, 2002approval8869d agoNUBAIN (NALBUPHINE HYDROCHLORIDE) — FDA approvalTrevi Therapeutics, Inc.

    Sponsor: PH HEALTH. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

    full page →fda approvals ↗
    ›Apr 17, 2002approval8868d agoHALDOL (HALOPERIDOL DECANOATE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Apr 18, 2002approval8867d agoDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approvalDoxil

    Sponsor: BAXTER HLTHCARE CORP. Form: INJECTABLE, LIPOSOMAL. Route: INJECTION

    full page →Doxil →fda approvals ↗
    ›Apr 18, 2002approval8867d agoENLON-PLUS (ATROPINE SULFATE) — FDA approvalAccord Healthcare Inc

    Sponsor: PHARMOBEDIENT. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Apr 18, 2002approval8867d agoENLON-PLUS (ATROPINE SULFATE) — FDA approvalAccord Healthcare Inc

    Sponsor: PHARMOBEDIENT. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    8859d ago
    DEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) — FDA approvalmedroxyprogesterone acetate

    Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION

    full page →medroxyprogesterone acetate →fda approvals ↗
    8856d ago
    PERCODAN (ASPIRIN) — FDA approvalEndo Pharmaceuticals Inc

    Sponsor: ENDO OPERATIONS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›May 1, 2002approval8854d agoPROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approvalalprostadil

    Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION

    full page →alprostadil →fda approvals ↗
    ›May 1, 2002approval8854d agoTRILEPTAL (OXCARBAZEPINE) — FDA approvalOXCARBAZEPINE

    Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

    full page →OXCARBAZEPINE →fda approvals ↗
    ›May 3, 2002approval8852d agoTRIAMTERENE AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalChartwell Pharmaceuticals LLC

    Sponsor: PHARMOBEDIENT. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    8846d ago
    BUSPIRONE HYDROCHLORIDE — FDA approvalOxford Pharmaceuticals LLC

    Sponsor: OXFORD PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›May 10, 2002approval8845d agoIMITREX (SUMATRIPTAN) — FDA approvalSUMATRIPTAN SUCCINATE

    Sponsor: GLAXOSMITHKLINE. Form: SPRAY. Route: NASAL

    full page →SUMATRIPTAN SUCCINATE →fda approvals ↗
    8840d ago
    ROXICET (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›May 16, 2002approval8839d agoLUPRON DEPOT-PED KIT (LEUPROLIDE ACETATE) — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: ABBVIE ENDOCRINE INC. Form: POWDER. Route: INTRAMUSCULAR

    full page →fda approvals ↗
    ›May 16, 2002approval8839d agoLUPRON (LEUPROLIDE ACETATE) — FDA approvalInvaGen Pharmaceuticals Inc

    Sponsor: ABBVIE ENDOCRINE INC. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›May 16, 2002approval8839d agoLUPRON (LEUPROLIDE ACETATE) — FDA approvalInvaGen Pharmaceuticals Inc

    Sponsor: ABBVIE ENDOCRINE INC. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›May 17, 2002approval8838d agoACTONEL (RISEDRONATE SODIUM) — FDA approvalAllergan Finance LLC

    Sponsor: APIL. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›May 17, 2002approval8838d agoACTONEL (RISEDRONATE SODIUM) — FDA approvalAllergan Finance LLC

    Sponsor: APIL. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    8833d ago
    ADDERALL XR 10 (AMPHETAMINE ASPARTATE) — FDA approvalTakeda Pharmaceuticals USA Inc

    Sponsor: TAKEDA PHARMS USA. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›May 23, 2002approval8832d agoDEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) — FDA approvalmedroxyprogesterone acetate

    Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION

    full page →medroxyprogesterone acetate →fda approvals ↗
    ›May 23, 2002approval8832d agoNIPENT (PENTOSTATIN) — FDA approvalpentostatin

    Sponsor: HOSPIRA INC. Form: INJECTABLE. Route: INJECTION

    full page →pentostatin →fda approvals ↗
    ›May 24, 2002approval8831d agoVALPROIC ACID — FDA approvalCereno Scientific AB

    Sponsor: PHARMOBEDIENT CNSLTG. Form: SYRUP. Route: ORAL

    full page →fda approvals ↗
    ›May 24, 2002approval8831d agoVFEND (VORICONAZOLE) — FDA approvalGreenstone LLC

    Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›May 24, 2002approval8831d agoVFEND (VORICONAZOLE) — FDA approvalGreenstone LLC

    Sponsor: PF PRISM CV. Form: POWDER. Route: INTRAVENOUS

    full page →fda approvals ↗
    8824d ago
    DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

    Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗
    8819d ago
    RITALIN LA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalRITALIN LA

    Sponsor: SANDOZ. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →RITALIN LA →fda approvals ↗
    ›Jun 6, 2002approval8818d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Jun 7, 2002approval8817d agoOXAPROZIN — FDA approvalSolubiomix LLC

    Sponsor: WATSON LABS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    $NVS156.44+0.92%
    $PFE24.79+1.00%
    $NVS156.44+0.92%
    $AYTU2.2300-0.89%
    $AMRX17.98+0.31%
    $IGC0.2670+0.41%
    $ASPU0.2893-0.26%
    $PFE24.79+1.00%
    $NVS156.44+0.92%
    $NVS156.44+0.92%
    $NVS156.44+0.92%
    $NVS156.44+0.92%
    $VTRS17.64+2.35%
    $TRVI
    $ABBV258.52-0.32%
    $PFE24.79+1.00%
    $PFE24.79+1.00%
    $NVS156.44+0.92%
    $PFE24.79+1.00%
    $ABBV258.52-0.32%
    $AMRX17.98+0.31%